Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
Guardado en:
Formato: | article |
---|---|
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f9adcb060bb4071b3c13a6fe4711307 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2f9adcb060bb4071b3c13a6fe4711307 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2f9adcb060bb4071b3c13a6fe47113072021-11-27T05:00:08ZCorrection: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study10.1136/jitc-2020-001694corr12051-1426https://doaj.org/article/2f9adcb060bb4071b3c13a6fe47113072021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e001694corr1.fullhttps://doaj.org/toc/2051-1426BMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
format |
article |
title |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
title_short |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
title_full |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
title_fullStr |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
title_full_unstemmed |
Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
title_sort |
correction: sars-cov-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study |
publisher |
BMJ Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/2f9adcb060bb4071b3c13a6fe4711307 |
_version_ |
1718409220980736000 |